Competing by Saving Lives:
How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
March 8, 2012 from 2:00-5:00 p.m
Thomson Reuters, 3 Times Square, New York City
Keynote by Professor Michael E. Porter
FSG with GBCHealth hosted an exclusive event on Creating Shared Value with Professor Michael E. Porter of Harvard Business School. Senior executives in global health gathered for a first look at new research findings that will impact the pharmaceutical and medical device industries. During a panel moderated by Jane Nelson of Harvard's Kennedy School of Government, leaders who are successfully facilitating shared value initiatives shared their stories. Then, peers in the industry collaborated during a shared value working session.
We enjoyed hosting leaders in global health from pharmaceutical and medical device companies, nonprofits, civil society, and government.
March 8th Agenda:
- Introductions by John Tedstrom, President and CEO, GBCHealth and Kyle Peterson, Managing Director, FSG
- Competing by Saving Lives Research Keynote by Michael E. Porter, Harvard Business School
- Shared Value Frontier Panel, moderated by Jane Nelson, Director, CSR Initiative at Harvard's Kennedy School, featuring: Gary Cohen, Executive Vice President, BD (Becton Dickinson and Company), Anuj Pasrija, Head, Social Business, Group Emerging Markets, Novartis Singapore, Michael J. Warmuth, Senior Vice President, Established Products, Pharmaceutical Products Group, Abbott
- Executive Peer Working Session: Developing an agenda to collectively accelerate Shared Value in Global Health
- Conclusion by Kyle Peterson, Managing Director, FSG
- Reception and networking to follow